Literature DB >> 23800596

Correlation between virulence gene expression and proton pump inhibitors and ambient pH in Clostridium difficile: results of an in vitro study.

David B Stewart1, John P Hegarty1.   

Abstract

Proton pump inhibitors (PPIs) are associated with the development of Clostridium difficile infection in humans. Though it is assumed that PPIs mediate this effect through gastric acid suppression, there has been little investigation into whether PPIs, or ambient pH, might directly affect the expression of C. difficile toxin genes. In the present study, C. difficile ribotypes 001, 027 and 078 obtained from human subjects were grown under anaerobic conditions prepared at pHs of 5, 7.3 and 9. Matched trios were exposed to 100 µM and 200 µM of omeprazole along with PPI untreated controls. Custom designed reverse transcription quantitative PCR hydrolysis probes were used to assess C. difficile gene expression for toxins A (tcdA), B (tcdB) and binary toxin (cdtB), as well as their positive regulators (tcdR and cdtR), using rrsA, which encodes 16S rRNA, as a constitutively expressed reference gene. tcdC and codY, negative regulators of toxin expression, were also assessed. Basic pH resulted in greater expression of tcdA, and with PPI exposure a 120-fold higher expression was noted with ribotype 001. tcdB and cdtB expressions were much less responsive to pH or PPIs, though a clear response to acidic pH and PPI exposure was observed in ribotype 027. tcdC and codY expressions were largely unaffected, except with ribotype 027; low pH and PPIs resulted in their greater expression, though to a lesser degree than with toxin genes and their positive regulators. Non-neutral pH and PPI exposure appear to have an effect on C. difficile, one that has a net effect towards toxin gene expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23800596     DOI: 10.1099/jmm.0.059709-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

Review 1.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

2.  The Impact of pH on Clostridioides difficile Sporulation and Physiology.

Authors:  Daniela Wetzel; Shonna M McBride
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

3.  Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

Authors:  Tadayuki Oshima; Liping Wu; Min Li; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-07-25       Impact factor: 7.527

4.  Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.

Authors:  Charlie T Seto; Patricio Jeraldo; Robert Orenstein; Nicholas Chia; John K DiBaise
Journal:  Microbiome       Date:  2014-11-25       Impact factor: 14.650

5.  Risk factors for poor outcome in community-onset Clostridium difficile infection.

Authors:  Eunyoung Lee; Kyoung-Ho Song; Ji Yun Bae; Doran Yoon; Joo-Hee Hwang; Pyoeng Gyun Choe; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Sang Won Park; Nam Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  Antimicrob Resist Infect Control       Date:  2018-06-15       Impact factor: 4.887

6.  Metabolic Effects of Bovine Milk Oligosaccharides on Selected Commensals of the Infant Microbiome-Commensalism and Postbiotic Effects.

Authors:  Louise M A Jakobsen; Maria X Maldonado-Gómez; Ulrik K Sundekilde; Henrik J Andersen; Dennis S Nielsen; Hanne C Bertram
Journal:  Metabolites       Date:  2020-04-24

7.  Risk Factors for BI/NAP1/027 Clostridioides difficile Infections and Clinical Outcomes Compared With Non-NAP1 Strains.

Authors:  Nandita S Mani; John B Lynch; Ferric C Fang; Jeannie D Chan
Journal:  Open Forum Infect Dis       Date:  2019-10-12       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.